Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedA new note 'No longer looking for participants' was added, signaling that recruitment for the study is closed. The page also includes new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates to the Intervention/Treatment heading and the revision footer (Revision: v3.6.0).SummaryDifference0.4%

- Check20 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer document revision. This update does not change any displayed study details or user-facing content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe revision tag on the page was updated to v3.5.4, replacing the previous v3.5.3. This indicates a software/document version update rather than a change to study content.SummaryDifference0.0%

- Check56 days agoChange Detected- The page now displays a new revision number, v3.5.3, replacing the previous v3.5.2, signaling a deployment update. This update appears to be a maintenance detail rather than a substantive change to study content or user-facing information.SummaryDifference0.0%

- Check70 days agoChange DetectedSite revision updated to version v3.5.2, replacing the previous v3.5.0 entry.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.